Online Now! Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy https://www.cell.com/cell-stem-cell/fulltext/S1934-5909(25)00187-0?rss=yes&utm_source=dlvr.it&utm_medium=mastodon #stemcells